(PQ 83)
INTERIM FINANCIAL STATEMENTS
FOR THE QUARTER ENDED 30th JUNE 2022.
Registered office: Level 04, Access Towers, No. 278, Union Place,
Colombo 2, Sri Lanka.
Tel: 94 11 4760000 , / Fax: 94 4760076
www.vidullanka.com
Vidullanka PLC | ||||
STATEMENT OF FINANCIAL POSITION | ||||
Group | Company | |||
As at | 30.06.2022 | 31.03.2022 | 30.06.2022 | 31.03.2022 |
(Unaudited*) | (Unaudited*) | (Unaudited*) | (Unaudited*) | |
Rs. | Rs. | Rs. | Rs. | |
ASSETS | ||||
Non-Current Assets | ||||
Property , Plant & Equipment | 8,543,250,135 | 7,540,452,121 | 637,216,867 | 632,600,803 |
Mature bearer biological assets | 46,671,847 | 46,592,900 | - | - |
Right of Use asset | 211,794,583 | 175,707,358 | 23,637,218 | 14,043,021 |
Investments in Subsidiaries | - | - | 1,328,896,131 | 1,328,896,131 |
Investments in Joint Ventures & Associates | 617,031,535 | 623,385,180 | 414,291,550 | 414,291,550 |
Other Project Investments | 68,411,434 | 66,565,678 | 68,411,434 | 66,565,678 |
Goodwill | 216,337,008 | 229,207,730 | 12,000,000 | 12,000,000 |
Deferred Tax Asset | 1,378,208 | 1,378,208 | - | - |
9,704,874,750 | 8,683,289,175 | 2,484,453,200 | 2,468,397,183 | |
Current Assets | ||||
Inventories | 149,079,852 | 123,802,571 | 27,751,134 | 21,604,537 |
Trade and Other Receivables | 2,224,150,591 | 1,650,684,162 | 911,291,707 | 733,386,992 |
Other Financial Assets | 275,350,646 | 160,340,030 | 41,105,925 | 41,427,730 |
Cash and Bank Balances | 822,819,320 | 849,460,536 | 6,138,301 | 37,260,783 |
3,471,400,409 | 2,784,287,299 | 986,287,067 | 833,680,042 | |
Total Assets | 13,176,275,159 | 11,467,576,474 | 3,470,740,267 | 3,302,077,225 |
EQUITY AND LIABILITIES | ||||
Capital and Reserves | ||||
Stated Capital | 1,794,669,350 | 1,786,069,350 | 1,794,669,350 | 1,786,069,350 |
Retaining Earnings | 2,526,803,250 | 2,412,474,194 | 68,224,631 | 82,760,234 |
Other components of equity | 2,175,822,955 | 1,453,327,291 | - | - |
Equity attributable to Equity Holders of the Parent | 6,497,295,555 | 5,651,870,835 | 1,862,893,981 | 1,868,829,584 |
Non Controlling Interest | 161,508,406 | 133,464,681 | - | - |
Total Equity | 6,658,803,961 | 5,785,335,516 | 1,862,893,981 | 1,868,829,584 |
Non- Current Liabilities | ||||
Loans and Borrowings | 3,274,770,405 | 3,131,161,366 | 543,932,428 | 533,832,873 |
Defined Benefit Liability | 46,414,174 | 44,169,534 | 41,998,241 | 42,426,155 |
Deferred Tax Liability | 819,719,161 | 649,659,510 | 21,269,364 | 21,018,879 |
Lease Liability | 77,737,434 | 69,753,196 | 17,671,622 | 6,551,931 |
4,218,641,174 | 3,894,743,606 | 624,871,654 | 603,829,838 | |
Current Liabilities | ||||
Loans and Borrowings | 1,601,336,852 | 1,246,655,142 | 734,931,763 | 601,586,938 |
Lease Liability | 16,233,450 | 7,594,247 | 2,275,736 | 3,290,202 |
Trade and Other Payables | 453,805,250 | 388,281,649 | 215,976,867 | 190,322,531 |
Income Tax Liability | 227,454,472 | 144,966,314 | 29,790,266 | 34,218,132 |
2,298,830,024 | 1,787,497,352 | 982,974,632 | 829,417,803 | |
Total Equity and Liabilities | 13,176,275,159 | 11,467,576,474 | 3,470,740,267 | 3,302,077,225 |
Net Assets Represented by : | ||||
No of Issued Shares-Voting | 864,124,198 | 862,124,198 | 864,124,198 | 862,124,198 |
No of Issued Shares-Non Voting | 72,394,086 | 72,394,086 | 72,394,086 | 72,394,086 |
Total No of Shares | 936,518,284 | 934,518,284 | 936,518,284 | 934,518,284 |
Net Asset Value Per Share (Rs) | 6.94 | 6.05 | 1.99 | 2.00 |
* The amounts are provisional and subject to audit |
These Financial Statements are in compliance with the requirement of the Companies Act No. 07 of 2007
(Signed)
………………………………………
Mafaz Ansar
Group Finance Controller
The Board of Directors is responsible for the Preparation and presentation of these financial statements.
(Signed) | (Signed) |
……………………………………… | ……………………………………… |
Riyaz M.Sangani | Rizvi Zaheed |
CEO | Director |
10th August 2022 |
1
Vidullanka PLC | ||||||
STATEMENT OF COMPREHENSIVE INCOME | ||||||
Group | Company | |||||
Quarter Ended 30th June | Quarter Ended 30th June | |||||
2022 | 2021 | Variance | 2022 | 2021 | Variance | |
(Unaudited*) | (Unaudited*) | (Unaudited*) | (Unaudited*) | |||
% | % | |||||
Rs. | Rs. | Rs. | Rs. | |||
Revenue | 775,233,281 | 606,816,953 | 28 | 78,543,691 | 116,622,209 | (33) |
Cost of Sales | (183,292,143) | (150,407,695) | (22) | (19,056,230) | (12,190,929) | (56) |
Gross Profit | 591,941,138 | 456,409,258 | 30 | 59,487,461 | 104,431,280 | (43) |
Other Income and Gain/(Losses) | (11,570,149) | 22,897,306 | (151) | 125,598,303 | 87,170,037 | 44 |
Administrative Expenses | (106,024,286) | (104,826,717) | (1) | (65,369,840) | (63,167,316) | (3) |
Finance Cost | (111,926,480) | (75,276,756) | (49) | (38,047,049) | (31,984,497) | (19) |
Finance Income | 225,424 | 336,121 | (33) | 208,462 | 331,846 | 37 |
Investment Share in the Joint Ventures & Associate | (6,347,117) | 26,496,496 | (124) | - | - | - |
Profit Before Tax | 356,298,530 | 326,035,707 | 9 | 81,877,337 | 96,781,350 | (15) |
Income Tax Expense | (138,149,754) | (82,855,745) | (67) | (563,820) | - | - |
Profit for the period | 218,148,776 | 243,179,962 | (10) | 81,313,517 | 96,781,350 | (16) |
Other Comprehensive Income (OCI) | ||||||
Net Actuarial Gain/(Loss) on Defined Benefit Plan | (1,468,448) | (54,419) | >999 | (1,455,633) | (75,016) | >999 |
- | ||||||
Income Tax on Other Comprehensive Income | 409,348 | 19,468 | >999 | 407,577 | 21,005 | >999 |
Net Actuarial Gain/(Loss) on Defined Benefit Plan of Investment | (6,527) | 4,507 | (245) | - | - | - |
share | ||||||
Exchange Differences on Translation of Foreign Operations | 748,471,931 | 19,485,713 | >999 | - | - | - |
Other Comprehensive Income for the Year, Net of Tax | 747,406,304 | 19,455,269 | >999 | (1,048,056) | (54,012) | >999 |
Total Comprehensive Income for the Year, Net of Tax | 965,555,080 | 262,635,231 | 268 | 80,265,461 | 96,727,338 | -17 |
Profit attributable to : | ||||||
Equity Holders of the Parent | 210,195,747 | 240,025,456 | (12) | 81,313,517 | 96,781,350 | (16) |
Non-Controlling Interest | 7,953,029 | 3,154,506 | 152 | - | - | - |
Total Profit for the period | 218,148,776 | 243,179,962 | (10) | 81,313,517 | 96,781,350 | (16) |
Total Comprehensive Income attributable to : | ||||||
Equity Holders of the Parent | 931,625,785 | 258,746,462 | 260 | 80,265,461 | 96,727,338 | (17) |
Non-Controlling Interest | 33,929,295 | 3,888,769 | 772 | - | - | - |
Total Comprehensive Income for the Year | 965,555,080 | 262,635,231 | 268 | 80,265,461 | 96,727,338 | (17) |
Earnings Per Share | 0.23 | 0.26 | 0.09 | 0.11 | ||
Weighted Average No of Shares | 929,611,639 | 917,136,645 | 929,611,639 | 917,136,645 |
2
STATEMENT OF CHANGES IN EQUITY
Vidullanka PLC
Foreign | |||||
Stated Capital | Retained | Currency | Non-Controlling | Total | |
Earnings | Translation | Interest | |||
GROUP | |||||
Reserve | |||||
Rs | Rs | Rs | Rs | Rs | |
Balance as at 1st April 2021 | 1,469,839,867 | 1,830,090,914 | 273,581,811 | 71,412,994 | 3,644,925,586 |
Profit for the Period | - | 240,025,456 | - | 3,154,506 | 243,179,962 |
Other Comprehensive Income | - | (30,444) | 18,751,450 | 734,263 | 19,455,269 |
Total Comprehensive Income for the Year | - | 239,995,012 | 18,751,450 | 3,888,769 | 262,635,231 |
Dividend Paid | - | (106,057,336) | - | - | (106,057,336) |
Subscription of Non Voting Shares | 253,379,301 | - | - | - | 253,379,301 |
Balance as at 30th June 2021 | 1,723,219,168 | 1,964,028,590 | 292,333,261 | 75,301,763 | 4,054,882,782 |
Balance as at 1st April 2022 | 1,786,069,350 | 2,412,474,194 | 1,453,327,291 | 133,464,681 | 5,785,335,516 |
Profit for the period | - | 210,195,747 | - | 7,953,029 | 218,148,776 |
Other Comprehensive Income | - | (1,065,627) | 722,495,664 | 25,976,266 | 747,406,304 |
Total Comprehensive Income for the Year | - | 209,130,120 | 722,495,664 | 33,929,295 | 965,555,080 |
Dividend Paid | - | (94,801,064) | - | (5,885,570) | (100,686,634) |
Subscription of ESOS | 8,600,000 | - | - | - | 8,600,000 |
Balance as at 30th June 2022 | 1,794,669,350 | 2,526,803,250 | 2,175,822,955 | 161,508,406 | 6,658,803,962 |
Stated Capital | Retained | Total | |
COMPANY | Earnings | ||
Rs | Rs | Rs | |
Balance as at 1st April 2021 | 1,469,839,867 | 37,598,029 | 1,507,437,896 |
Profit for the Period | - | 96,781,350 | 96,781,350 |
Other Comprehensive Income | - | (54,012) | (54,012) |
Total Comprehensive Income for the Year | - | 96,727,338 | 96,727,338 |
Dividend Paid | - | (106,057,336) | (106,057,336) |
Subscription of Non Voting Shares | 253,379,301 | 253,379,301 | |
Balance as at 30th June 2021 | 1,723,219,168 | 28,268,031 | 1,751,487,199 |
Balance as at 1st April 2022 | 1,786,069,350 | 82,760,234 | 1,868,829,584 |
Profit for the period | - | 81,313,517 | 81,313,517 |
Other Comprehensive Income | - | (1,048,056) | (1,048,056) |
Total Comprehensive Income for the Year | - | 80,265,461 | 80,265,461 |
Dividend Paid | - | (94,801,064) | (94,801,064) |
Subscription of ESOS | 8,600,000 | - | 8,600,000 |
Balance as at 30th June 2022 | 1,794,669,350 | 68,224,631 | 1,862,893,981 |
3
STATEMENT OF CASH FLOWS | Vidullanka PLC | |||
Group | Company | |||
As at | 30.06.2022 | 30.06.2021 | 30.06.2022 | 30.06.2021 |
(Unaudited*) | (Unaudited*) | (Unaudited*) | (Unaudited*) | |
Rs. | Rs. | Rs. | Rs. | |
Cash Flows From/(Used in ) Operating Activities | ||||
Profit from Ordinary Activities Before Tax | 356,298,530 | 326,035,707 | 81,877,337 | 96,781,350 |
Adjustments for | ||||
Depreciation Property, Plant and Equipment | 82,245,522 | 54,526,797 | 7,851,949 | 5,634,366 |
Depreciation Biological Assets | 2,954,623 | 2,479,520 | - | - |
Amortization of Right to Use Assets | 4,104,208 | 4,102,095 | 1,279,638 | 1,461,691 |
Expenses on Defined Benefit Plan | (272,339) | 1,781,377 | 13,230 | 1,263,698 |
Dividend Income | - | (124,355,000) | (65,400,000) | |
Provision for Impairment / Written Off | 7,500,000 | 7,500,000 | 7,500,000 | 7,500,000 |
Impairment / Written -Off - Biological asset | 344,380 | 344,380 | - | |
Net (Gain) / Loss on Translation of Foreign Currency | 158,760,043 | 2,816,687 | - | |
Share of Profits from Joint Ventures | 6,347,117 | (26,496,496) | - | - |
Finance Income | (228,535) | (550,174) | (208,462) | (331,846) |
Finance Cost | 111,926,480 | 75,276,756 | 38,047,049 | 31,984,497 |
Amortization of Goodwill | 12,870,723 | 12,870,723 | - | - |
Operating Profit/(Loss) Before Working Capital Changes | 742,850,751 | 460,687,372 | 12,005,740 | 78,893,756 |
(Increase)/Decrease in Inventories | (7,319,297) | (6,588,869) | (6,146,597) | (569,547) |
(Increase)/Decrease in Trade & Other Receivables | (610,904,141) | (182,780,753) | (177,904,715) | 6,075,242 |
Increase/(Decrease) in Trade & Other Payables | 247,268,820 | 47,979,812 | 25,654,336 | (27,624,066) |
Cash Generated from Operations | 371,896,132 | 319,297,562 | (146,391,236) | 56,775,384 |
Finance Cost Paid | (110,624,111) | (65,917,243) | (38,047,049) | (14,299,652) |
Defined Benefit Plan Costs Paid | (1,489,200) | (1,849,600) | (1,489,200) | (1,849,600) |
Income Tax Paid | (25,605,688) | (9,000,000) | (4,833,244) | - |
Net Cash From Operating Activities | 234,177,134 | 242,530,719 | (190,760,729) | 40,626,132 |
Net Cash From (Used In ) Investing Activities | ||||
Acquisition of Property, Plant and Equipment | (16,714,733) | (22,968,334) | (12,375,974) | (508,340) |
Investment in Biological Assets | (94,180) | - | - | - |
Acquisition of Right to Use Asset | (10,873,835) | - | (10,873,835) | - |
Proceeds from sale of Property, Plant and Equipment | - | - | - | - |
Investment in New Projects | (9,345,756) | 4,781,438 | (9,345,756) | 4,781,438 |
Net Investment on Other Financial Assets | (87,337,909) | (73,839,171) | 321,805 | (73,839,171) |
Finance Income Received | 225,663 | 545,899 | 208,462 | 331,846 |
Dividend Received | - | 15,300,000 | 124,355,000 | 65,400,000 |
Net Cash Flow Used in Investing Activities | (124,140,749) | (76,180,168) | 92,289,703 | (3,834,228) |
Cash From (Used in ) Financing Activities | ||||
Proceeds from Right Issue | - | 253,379,301 | - | 253,379,301 |
Proceeds from ESOS | 8,600,000 | - | 8,600,000 | - |
Dividend Payments | (100,686,634) | (106,057,336) | (94,801,064) | (106,057,336) |
Principal Payment under Ijara-Leases (Motor Vehicle) | (1,153,434) | (1,307,822) | (790,434) | (963,869) |
Principal Payment under SLFRS 16 - Non- Motor | (3,376,584) | (3,214,390) | (551,585) | (486,388) |
Principal Payment under Diminishing Musharakah Facilities | (215,365,274) | (126,567,375) | (10,412,700) | (4,166,700) |
Principal Payment Short Term Facilities | (41,389,338) | (285,000,000) | (41,389,338) | (285,000,000) |
Proceeds from Wakala Facilities | 10,000,000 | - | - | - |
Proceeds from SLFRS 16 - Non- Motor | 11,447,238 | - | 11,447,238 | - |
Proceeds from Diminishing Musharakah Facilities | 14,984,562 | - | 14,984,562 | - |
Proceeds from Short Term Facilities | 180,261,863 | 279,767 | 180,261,863 | 279,767 |
Net Cash From (Used In ) Financing Activities | (136,677,600) | (268,487,856) | 67,348,542 | (143,015,226) |
Net Increase/(Decrease) in Cash & Cash Equivalents | (26,641,216) | (102,137,305) | (31,122,482) | (106,223,321) |
Cash & Cash Equivalents at the beginning of period | 849,460,536 | 423,098,790 | 37,260,783 | 116,028,674 |
Cash & Cash Equivalents at end of period | 822,819,320 | 320,961,485 | 6,138,301 | 9,805,353 |
Movement in cash and cash equivalents | ||||
Components of Cash and Cash Equivalents | 362,500 | 362,500 | 225,000 | 225,000 |
Cash and Bank Balances | 822,456,820 | 320,598,985 | 5,913,301 | 9,580,353 |
At the end of the period | 822,819,320 | 320,961,485 | 6,138,301 | 9,805,353 |
* The amounts are provisional and subject to audit
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Vidullanka plc published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 02:33:07 UTC.